openPR Logo
Press release

Deadline coming up on June 11, 2024 in Lawsuit for Investors in QuidelOrtho Corporation (NASDAQ: QDEL)

A Deadline is coming up on June 11, 2024 in the lawsuit for certain investors in QuidelOrtho Corporation (NASDAQ: QDEL).

A Deadline is coming up on June 11, 2024 in the lawsuit for certain investors in QuidelOrtho Corporation (NASDAQ: QDEL).

A deadline is coming up on June 11, 2024 in the lawsuit filed for certain investors of QuidelOrtho Corporation (NASDAQ: QDEL) over alleged securities laws violations by QuidelOrtho Corporation.

Investors who purchased shares of QuidelOrtho Corporation (NASDAQ: QDEL) have certain options and there are strict and short deadlines running. Deadline: June 11, 2024. NASDAQ: QDEL stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Southern District of New York the plaintiff alleges on behalf of purchasers of QuidelOrtho Corporation (NASDAQ: QDEL) common shares between February 18, 2022 and April 1, 2024, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between February 18, 2022 and April 1, 2024, the Defendants misled investors by making statements that were false and misleading when made because they knew or deliberately disregarded and failed to disclose the following adverse facts about QuidelOrtho's business, operations, and prospects that QuidelOrtho sold more COVID-19 tests to its distributors and pharmacy chain customers than they could resell to healthcare providers and end customers, that excess inventories of COVID-19 tests existed throughout the supply chain, that, as a result of (a)-(b), QuidelOrtho's distributors and pharmacy chain customers were poised to significantly reduce their COVID-19 test orders, that undisclosed problems created a heightened risk that the Savanna RVP4 Test would experience a delayed commercial launch in the United States, and that, as a result of (a)-(d), Defendants lacked a reasonable basis for their positive statements about QuidelOrtho's business, financials, and growth trajectory.

Those who purchased shares of QuidelOrtho Corporation (NASDAQ: QDEL) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Deadline coming up on June 11, 2024 in Lawsuit for Investors in QuidelOrtho Corporation (NASDAQ: QDEL) here

News-ID: 3521900 • Views:

More Releases from Shareholders Foundation, Inc.

Lawsuit Alert: Investors who lost money with shares of Molina Healthcare, Inc. (NYSE: MOH) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Molina Healthcare, Inc. ( …
An investor, who purchased shares of Molina Healthcare, Inc. (NYSE: MOH), filed a lawsuit over alleged violations of Federal Securities Laws by Molina Healthcare, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Molina Healthcare, Inc. (NYSE: MOH) have certain options and for certain investors are short and strict deadlines running. Deadline: December 02, 2025. NYSE: MOH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
CTO Realty Growth, Inc. (NYSE: CTO) Long Term Investor Alert: Investigation of potential Wrongdoing
CTO Realty Growth, Inc. (NYSE: CTO) Long Term Investor Alert: Investigation of p …
An investigation on behalf of current long-term investors in shares of CTO Realty Growth, Inc. (NYSE: CTO) concerning potential breaches of fiduciary duties by certain directors and officers of CTO Realty Growth, Inc. was announced. Investors who are current long term investors in CTO Realty Growth, Inc. (NYSE: CTO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a
Lawsuit filed for Investors who lost money with shares of Marex Group plc (NASDAQ: MRX)
Lawsuit filed for Investors who lost money with shares of Marex Group plc (NASDA …
An investor, who purchased shares of Marex Group plc (NASDAQ: MRX), filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Marex Group plc in connection with certain allegedly false and misleading statements. Investors who purchased a significant amount of shares of Marex Group plc (NASDAQ: MRX) between May 16, 2024 and August 5, 2025, have certain options
LifeMD, Inc. (NASDAQ: LFMD) Investor Alert: Deadline in Lawsuit on October 27, 2025
LifeMD, Inc. (NASDAQ: LFMD) Investor Alert: Deadline in Lawsuit on October 27, 2 …
A deadline is coming up on October 27, 2025 in the lawsuit filed for certain investors of LifeMD, Inc. (NASDAQ: LFMD) over alleged securities laws violations by LifeMD, Inc. Investors who purchased shares of LifeMD, Inc. (NASDAQ: LFMD) have certain options and there are strict and short deadlines running. Deadline: October 27, 2025. LifeMD, Inc. (NASDAQ: LFMD) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for QuidelOrtho

United States Point-of-Care Diagnostics Market Size, Growth & Forecast | Major P …
"Point of Care Diagnostics Market reached US$ 44.72 Billion in 2024 and is expected to reach US$ 106.35 Billion by 2033, growing at a CAGR of 10.7% during the forecast period 2025-2033." As per DataM intelligence research report Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/point-of-care-diagnostics-market?sp United States: Recent Industry Developments ✅ In September 2025, Abbott Laboratories launched a next-generation point-of-care diagnostic device for rapid detection of infectious diseases,
Lyme Disease Diagnostics Market Poised for Growth Amid Rising Incidence Rates | …
Lyme Disease Diagnostics Market Overview Lyme Disease Diagnostics Market is projected to grow from USD 960 million in 2025 to USD 1.65 billion by 2032, registering a CAGR of 7.9%. The latest report (2025-2032) on the Lyme Disease Diagnostics Market by Coherent Market Insights offers an in-depth analysis of market trends, growth factors, challenges, and competition. It explores market size, revenue, production, consumption, and CAGR, using reliable research methods for accuracy. The
Arbovirus Testing Market Is Booming So Rapidly | DiaSorin, QuidelOrtho, NovaTec
The Global Arbovirus Testing Market Size is estimated at $1.4 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 4.6% to reach $2.1 Billion by 2034. The latest study released on the Global Arbovirus Testing Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Arbovirus Testing market study covers significant research data and proofs to be a handy resource document for
Chemiluminescence Immunoassay Market Projected To Witness Substantial Growth, 20 …
Global chemiluminescence immunoassay market is estimated to be valued at USD 14.00 Bn in 2025 and is expected to reach USD 22.21 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032. The Latest study titled Chemiluminescence Immunoassay Market 2025, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2025 to 2032. The comprehensive
U.S. Blood Transfusion Diagnostics Market Size, Trends, Growth, Opportunities | …
The U.S. blood transfusion diagnostics market was valued at USD 1.91 billion in 2021 and is projected to grow from USD 2.20 billion in 2022 to USD 3.58 billion by 2029, recording a CAGR of 7.2% during the forecast period. The U.S. Blood Transfusion Diagnostics Market is witnessing remarkable growth, driven by advancements in diagnostic technologies, increasing demand for safe blood transfusions, and stringent regulatory standards. The market focuses on ensuring
Investigation announced for Investors in shares of QuidelOrtho Corporation (NASD …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of QuidelOrtho Corporation. Investors who are current long term investors in QuidelOrtho Corporation (NASDAQ: QDEL) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: QDEL stocks follows a lawsuit filed against QuidelOrtho Corporation over